LEVANT 2 Safety Registry

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1189 participants.

Also called NCT01790243

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,189 participants (enrolled count) (from the registry)
Sponsor
  • C. R. Bard Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01790243
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01790243. Randomized; no masking; primary purpose treatment. Start 2011-07-20 (actual); primary completion 2015-11-27 (actual). Results posted on 2020-06-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
LEVANT 2 Safety Registry
Condition
Peripheral Artery Disease
Condition
Femoropopliteal Artery Occlusion
Condition
Femoropopliteal Stenosis
Intervention (Device)
Lutonix Drug Coated Balloon
Intervention (Device)
Standard PTA Balloon
Lead sponsor
C. R. Bard (class: industry)

Record details

Record id
cardio:ct-nct01790243
Content hash
864392656afe9581e1a32ade47ef7c01c5878380438d2fea9493f4c677c2a0fb